Assyro AI

Orange Book product · Brand (NDA)

NOCTIVA

DESMOPRESSIN ACETATE

Brand (NDA)NDA 201656DISCN ACERUS PHARMS

At a glance

Mar 03, 2017

Approved

Brand (NDA)

Application

Not listed

TE code

3

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 03, 2017

    9 yr 5 mo ago

  2. Today

  3. Patent 11419914 expires

    Listed method-of-use patent (U-3431) expiration.

    Jun 15, 2030

    in 4 yr 1 mo

  4. Patent 12090190 expires

    Listed drug product patent expiration.

    Jun 15, 2030

    in 4 yr 1 mo

  5. Patent 9539302 expires

    Listed drug product patent expiration.

    Jun 15, 2030

    in 4 yr 1 mo

Pharmaceutical detail

Active ingredient

DESMOPRESSIN ACETATE

Strength

0.00083MG/SPRAY

Dosage form

SPRAY, METERED

Route

NASAL

TE code

Not listed

Application

NDA 201656

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (3)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
11419914Jun 15, 2030in 4 yr 1 mo
U-3431
12090190Jun 15, 2030in 4 yr 1 mo
ProductU-4003
9539302Jun 15, 2030in 4 yr 1 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.